SCOTT SMITH: Open Payments
NPI 1336257617 · PLEASANT GROVE, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$820 in 45 payments from 19 companies in 2025. Trend: 2023 $946 · 2024 $1,027 · 2025 $820
Food & beverage: $820
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $279 |
| Phathom Pharmaceuticals, Inc. | 6 | $86 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $75 |
| Viatris Specialty LLC | 3 | $67 |
| Supernus Pharmaceuticals, Inc. | 2 | $34 |
| GlaxoSmithKline, LLC. | 2 | $29 |
| Edwards Lifesciences Corporation | 1 | $29 |
| Neuronetics, Inc. | 1 | $22 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $22 |
| Dexcom, Inc. | 1 | $21 |
Products named: VRAYLAR, QULIPTA, VOQUEZNA, Kerendia, YUPELRI, UBRELVY, Qelbree, SHINGRIX.
Industry payments across UT — which companies pay providers there.
